LETTER
ortho-Directing Group in the Lithiation of Pyridine
1911
4-Formyl-3-tetrahydropyran-2-yloxy Pyridine (6)
From 160 mg (0.89 mmol) of 1 and 140 mL DMF (1.78 mmol), 160
mg of compound 6 were obtained (89%) as brown oil. H NMR
(CDCl3): d = 1.50–2.00 (6 H, m), 3.65 (1 H, m), 3.90 (1 H, m), 5.66
(1 H, t, J = 2.9 Hz), 7.61 (1 H, d, J = 4.89 Hz), 8.42 (1 H, d, J = 4.89
Hz), 8.76 (1 H, s), 10.58 (1 H, s). 13C NMR: d = 18.8, 25.2, 30.4,
62.8, 97.6, 120.0, 130.0, 140.3, 143.7, 153.9, 189.6.
Hz), 7.28 (1 H, d, J = 8.7 Hz), 7.43 (1 H, s), 7.50 (5 H, m), 7.82 (1
H, d, J = 5.8 Hz). 13C NMR: d = 55.4, 70.9, 113.9, 114, 119.9,
128.2, 128.4, 130.6, 130.8, 134, 135.6, 136, 145.4, 147.4, 159.1.
HRMS: m/z calcd for C19H18NO3S [M]+: 340.0991; found:
340.1007.
1
Competition Experiments
Competition experiment involving 3-methoxy and 3-(O-THP)pyri-
2-Deuterio-4-phenylsulfanyl-3-tetrahydropyran-2-yloxy
Pyridine (10)
dine was conducted using the experimental conditions described for
2.
From 200 mg (1.12 mmol) of 1, after successive treatments with n-
BuLi (1.34 mmol), PhSSPh (330 mg, 1.46 mmol), then n-BuLi
(1.68 mmol) and D2O (0.1 mL, 5.6 mmol), 190 mg were obtained
(59%) after column chromatography as a pale brown oil. 1H NMR
(CDCl3): d = 1.50–2.00 (6 H, m), 3.50–3.70 (2 H, m), 5.52 (1 H, t,
J = 2.6 Hz), 6.45 (1 H, d, J = 4.5 Hz), 7.40–7.50 (5 H, m), 7.92 (1
H, d, J = 4.5 Hz). MS (CI): m/z = 85, 205, 289.
Competition Experiment with the Carbamate
From 100 mg (0.56 mmol) of 1 and 110 mg (0.56 mmol) of 3-O-di-
ethylcarbamoylpyridine, 150 mg of the following mixture were ob-
1
tained as a colorless oil. H NMR (CDCl3): d = 1.23 (6 H, 2 t,
J = 7.1 Hz), 1.50–2.00 (6 H, m), 3.42 (4 H, 2q, J = 7.0 Hz), 3.61 (1
H, m), 3.86 (1 H, m), 5.44 (1 H, t, J = 2.9 Hz), 7.20 (1 H, dd, J = 8.5,
4.5 Hz), 7.30 (1 H, d, J = 4.3 Hz), 7.38 (0.57 H, H4 of the THP
ether, ddd, J = 8.3, 2.8, 1.3 Hz), 7.52 (0.03 H, H4 of the carbamate,
ddd, J = 8.1, 4.3, 1.1 Hz), 8.10 (1 H, d, J = 4.2 Hz), 8.41 (1 H, s),
8.43 (1 H, s), 8.43 (1 H, d, J = 4.3 Hz).
Procedure for Subsequent Deprotection
After metallation (with 2 mol equiv n-BuLi 45 min at –78 °C) and
electrophilic trapping (45 min at –78 °C), the crude material was
taken up in dioxane and an equal volume of 6 M aq HCl was added.
After 2 h stirring at r.t., solvents were evaporated in vacuo and the
residue was dissolved in H2O, washed with Et2O and lyophilized to
afford pure 7–9 as their hydrochlorides.
3-Deuterio-4-tetrahydropyran-2-yloxy Pyridine (14a)
From 100 mg (0.56 mmol) of 13 and 160 mL (2.79 mmol) EtOD, 65
mg of 14a (65%) were obtained. 1H NMR: d = 1.50–2.00 (6 H, m),
3.50–3.70 (2 H, m), 5.46 (1 H, t, J = 2.8 Hz), 6.88 (1 H, d, J = 5.6
Hz), 8.36 (1 H, s), 8.37 (1 H, d, J = 5.6 Hz). 13C NMR: d = 18.7,
25.5, 30.2, 69.3, 93.7, 131.6, 153.1, 164.0.
3-Hydroxy-4-phenylsulfanyl Pyridine Hydrochloride (7)
From 150 mg (0.84 mmol) of 1 and 364 mg (1.67 mmol) diphenyl-
disulfide, 150 mg of compound 7 were obtained (75%) as a white
powder; mp 238 °C. 1H NMR (DMSO): d = 6.85 (1 H, d, J = 6.21
Hz), 7.67 (5 H, m), 8.13 (1 H, d, J = 6.21 Hz), 8.19 (1 H, s). 13C
NMR: d = 121.8, 125.6, 127, 131.8, 132.0, 133.7, 136.7, 150.2,
151.8. MS (FAB+): m/z = 204, 185, 93, 75. HRMS: m/z calcd for
C11H9NOS [M]+: 203.0404; found: 203.0405.
3-Deuterio-1-tetrahydropyran-2-yloxy Pyridin-4-one (14b)
From the previous experiment, 27 mg of 14b (27%) were obtained
by crystallization as a white solid. 1H NMR (CDCl3): d = 1.50–2.00
(6 H, m), 3.60–4.10 (2 H, m), 4.78 (1 H, dd, J = 10.0, 2.2 Hz), 6.32
(1 H, d, J = 8.1 Hz), 7.41 (2 H, m). 13C NMR: d = 22.9, 24.9, 32.3,
69.3, 91.7, 118.5, 118.7, 137.4, 137.5, 180.2.
3-Hydroxy-4-(4-methoxyphenylhydroxymethyl) Pyridine
Hydrochloride (8)
3-Iodo-4-tetrahydropyran-2-yloxy Pyridine (15a)
From 150 mg (0.84 mmol) of 1 and 200 mL 4-anisaldehyde, 150 mg
of compound 8 were obtained (67%) as a light brown powder; mp
82 °C. 1H NMR (D2O): d = 3.71 (3 H, s), 6.10 (1 H, s), 6.87 (1 H, d,
J = 8.8 Hz), 7.25 (1 H, d, J = 8.8 Hz), 8.12 (1 H, d, J = 6.2 Hz), 8.13
(1 H, s), 8.29 (1 H, d, J = 6.2 Hz). 13C NMR: d = 55.6, 69.5, 114.5,
124.2, 127.9, 129.2, 132.3, 133.4, 150.6, 152.8, 159.2. MS (FAB+):
m/z = 232, 214, 185, 93, 75. HRMS: m/z calcd for C13H13NO3 [M]+:
231.0891; found: 231.0895.
From 100 mg (0.56 mmol) of 13 and 210 mg (0.83 mmol) I2, 40 mg
of 15a were obtained (24%) as a brown oil. H NMR (CDCl3):
d = 1.50–2.00 (6 H, m), 3.50–3.70 (2 H, m), 5.61 (1 H, t, J = 2.9
Hz), 6.94 (1 H, d, J = 5.6 Hz), 8.28 (1 H, d, J = 5.6 Hz), 8.71 (1 H,
1
s).
3-Iodo-1-tetrahydropyran-2-yloxy Pyridin-4-one (15b)
From the previous experiment, 45 mg of 15b (26%) were obtained
1
by crystallization as a yellow solid. H NMR (CDCl3): d = 1.50–
3-Hydroxy-4-methyl Pyridine Hydrochloride (9)
2.00 (6 H, m), 3.60 (1 H, m), 4.11 (1 H, m), 4.79 (1 H, dd, J = 10.0,
2.1 Hz), 6.33 (1 H, d, J = 7.5 Hz), 7.41 (1 H, dd, J = 7.5, 2.4 Hz),
8.00 (1 H, d, J = 2.4 Hz). 13C NMR: d = 21.5, 23.5, 31.1, 68, 90.1,
91.9, 113, 135.8, 141.4, 174.3. MS (CI): m/z = 306, 222, 180, 96,
85, 73.
From 105 mg (0.59 mmol) of 1 and 55 mL iodomethane (0.88
mmol), 82 mg of compound 9 were obtained (96%) as a brown
paste. 1H NMR (DMSO): d = 2.41 (3 H, s), 7.86 (1 H, d, J = 5.6 Hz),
8.34 (1 H, d, J = 5.6 Hz), 8.42 (1 H, s). 13C NMR: d = 17.3, 127.2,
129.3, 132.9, 146.6, 155.9.
3-(4-Methoxyphenylhydroxymethyl)-4-tetrahydropyran-2-
yloxy Pyridine (16a)
From 100 mg (0.56 mmol) of 13 and 100 mL (0.83 mmol) of 4-anis-
3-Hydroxy-2-(4-methoxyphenyl)hydroxymethyl-4-phenylsulfa-
nyl Pyridine Hydrochloride (11)
1
From 100 mg (0.56 mmol) of 1, n-BuLi (1.12 mmol, 45 min at
–78 °C), 244 mg diphenyldisulfide (1.12 mmol, 45 min at –78 °C),
135 mL 4-anisaldehyde (1.12 mmol, 45 min at –78 °C), then hydro-
lyzing as described for 7–9, 156 mg of compound 11 were obtained
(74%) as a white powder; mp 112 °C. 1H NMR (DMSO): d = 3.65
(3 H, s), 6.17 (1 H, s), 6.48 (1 H, d, J = 5.8 Hz), 6.83 (1 H, d, J = 8.7
aldehyde, 120 mg of 16a were obtained (68%) as a white oil. H
NMR (CDCl3): d = 1.50–2.00 (6 H, m), 3.47 (2 H, m), 3.71 (3 H, s),
5.44 (1 H, m), 5.90 (1 H, s), 6.78 (2 H, d, J = 8.8 Hz), 6.94 (1 H, d,
J = 5.6 Hz), 7.22 (2 H, d, J = 8.8 Hz), 8.34 (1 H, d, J = 5.6 Hz), 8.56
(1 H, s). 13C NMR: d = 19.3, 25.9, 30, 55.7, 65.3, 69.2, 96, 103,
114.1, 118.1, 128.5, 130.3, 148,150.6, 159, 172.7.
Synlett 2006, No. 12, 1908–1912 © Thieme Stuttgart · New York